Hansa Biopharma AB operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hansa Biopharma AB with three other
companies in this sector in Sweden:
Q linea AB
sales of 1.07 million Swedish Kronor [US$114,968.10 ]
Biovica International AB
(2.72 million Swedish Kronor [US$293,675.55 ]
Diamyd Medical Ab
(726,000.00 Swedish Kronor [US$78,299.10 ]
During the year ended December of 2018, sales at
Hansa Biopharma AB were SEK 3.36 million (US$362.16 thousand).
decrease of 2.4%
versus 2017, when the company's sales were SEK 3.44 million.